Louis-David Cantin

Louis-David Cantin has over 17 years of experience in the pharmaceutical industry. From 2001 to 2007, they worked at Bayer Healthcare, starting as a Research Scientist and eventually becoming a Senior Research Scientist II. During this time, they managed the chemical inventory and purchasing, was a Project Chemistry Leader and R&D Project Co-Leader, and led an international IT project-team. In 2007, they moved to AstraZeneca as an Assistant Director of Medicinal Chemistry. In 2012, they became an Advisor to the CEO at gIcare pharma inc. Since 2013, they have been President of Groupe PARIMA Inc, a Development and Manufacturing Organization (CDMO) specialized in the development and manufacturing of pharmaceutical products. In this role, they oversee product development activities and quality control activities, as well as client relations, compliance and P&L. Louis-David is also responsible for the elaboration and execution of the marketing strategy.

Louis-David Cantin obtained a Diploma of Collegiate Education from Collège Jean-de-Brébeuf in 1989-1991, followed by a B.Sc. in Chemistry and Biology from Eckerd College in 1991-1994. Louis-David then completed a M.Sc. and Ph.D. in Organic Chemistry from Université de Montréal in 1994-1999, and a Post. Doc in Organic Chemistry from the University of Pennsylvania in 1999-2001. Finally, they obtained an MBA from École des sciences de la gestion (ESG UQAM) in 2012-2014.